Blog
RSS FeedPosted by Michael Wonder on 11 Mar 2022
ATAGI update following weekly COVID-19 meeting (9 March 2022)
11 March 2022 - ATAGI have not made any new updates since 2 March 2022. ...
Posted by Michael Wonder on 10 Mar 2022
COVID-19 vaccine weekly safety report (10 March 2022)
10 March 2022 - To 6 March 2022, the TGA has received 460 reports which have been assessed as likely ...
Posted by Michael Wonder on 03 Mar 2022
COVID-19 vaccine weekly safety report (3 March 2022)
3 March 2022 - This is the 52nd issue of the COVID-19 vaccine safety report. ...
Posted by Michael Wonder on 24 Feb 2022
COVID-19 vaccine weekly safety report (24 February 2022)
24 February 2022 - To 20 February 2022, the TGA has received 451 reports which have been assessed as likely to ...
Posted by Michael Wonder on 17 Feb 2022
COVID-19 vaccine weekly safety report (17 February 2022)
17 February 2022 - To 13 February 2022, the TGA has received 449 reports which have been assessed as likely to ...
Posted by Michael Wonder on 14 Feb 2022
EMA starts safety review of Janus kinase inhibitors for inflammatory disorders
11 February 2022 - EMA’s safety committee, PRAC, has started a review of the safety of Janus kinase (JAK) inhibitors ...
Posted by Michael Wonder on 10 Feb 2022
COVID-19 vaccine weekly safety report (10 February 2022)
10 February 2022 - To 6 February 2022, the TGA has received 446 reports which have been assessed as likely to ...
Posted by Michael Wonder on 07 Feb 2022
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
3 February 2022 - The U.S. FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib) ...
Posted by Michael Wonder on 04 Feb 2022
To hell and back: devices meant to ease pain are causing trauma
5 February 2022 - A $35,000 treatment at the forefront of medical technology which pumps electric pulses into the spine ...
Posted by Michael Wonder on 03 Feb 2022
COVID-19 vaccine weekly safety report (3 February 2022)
3 January 2022 - To 30 January 2022, the TGA has received 440 reports which have been assessed as likely ...
Posted by Michael Wonder on 31 Jan 2022
ATAGI update following weekly COVID-19 meeting (27 January 2022)
31 January 2022 - On Thursday 27 January 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. ...
Posted by Michael Wonder on 27 Jan 2022
COVID-19 vaccine weekly safety report (27 January 2022)
27 January 2022 - To 23 January 2022, the TGA has received 431 reports which have been assessed as likely to ...
Posted by Michael Wonder on 20 Jan 2022
COVID-19 vaccine weekly safety report (20 January 2022)
20 January 2022 - To 16 January 2022, the TGA has received 428 reports which have been assessed as likely to ...
Posted by Michael Wonder on 18 Jan 2022
TGA ‘knowingly putting pharmacists in serious danger’
18 January 2022 - The pharmacists’ union has accused the medical regulator of putting workers and customers at risk of ...
Posted by Michael Wonder on 18 Jan 2022
COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
18 January 2022 - Vaccination remains a major pillar of the response to COVID-19, particularly as variants of the virus continue ...